Notable Call Buying Activity Continues in Celgene (CELG) Following Reported Acquisition of Juno Therapeutics (JUNO) -Susquehanna

Susquehanna options strategist Alison Edwards notes call buying activity in Celgene (NASDAQ: CELG), as an investor bought 3k Mar 110 Calls for $2.85, adding to Feb call buying yesterday, following CELG's reported acquisition of Juno Therapeutics (NASDAQ: JUNO) for $87 per share.

You May Also Be Interested In

• DoJ approves Paramount's acquisition of Warner Bros - Politico
• AST SpaceMobile (ASTS) call put ratio 3.2 calls to 1 put, share price down 10%
• Western Digital (WDC) call put ratio 1.3 calls to 1 put a focus on July 500 puts